NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Primary osteoporosis
Date of first enrollment	12/09/2005
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : EHDP (Etidronate Disodium) INN of investigational material : Therapeutic category code : 399 Agents affecting metabolism, n.e.c. Dosage and Administration for Investigational material : Oral

Outcome(s)

Primary Outcome	Efficacy: Incidences of vertebral fracture, etc.
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	>= 50age old
Age maximum	<= 76age old
Gender	Both
Include criteria	<Inclusion criteria> -Primary osteoporosis -Patient who had none or one to four vertebral (T4-L5) fracture(s) -Menopausal or postmenopausal woman or man aged 50 to less than 77 -Patients who can walk (hospitalization/outpatient) etc. <Exclusion criteria> -Secondary osteoporosis -Other diseases with reduced bone mass except secondary osteoporosis -Radiographic finding that might affect the vertebral intensity etc.
Exclude criteria